openPR Logo
Press release

Sales Revenue of Hereditary Orotic Aciduria treatment Market to Soar in the Near Future Owing to Growing Consumer Adoption

12-18-2018 04:45 AM CET | Health & Medicine

Press release from: Persistence Market Research

Sales Revenue of Hereditary Orotic Aciduria treatment Market

Hereditary orotic aciduria is a condition refers to an excessive excretion of orotic acid in the urine. Orotic acid is an intermediate product produced during the pyrimidine synthesis pathway. Hereditary orotic aciduria is a rare autosomal recessive disorder. Hereditary oratic disorder may be caused by a deficiency in enzyme UMPS. UMPS is a bifunctional protein that consists of the enzyme activities of orotate phosphoribosyltransferse and orotidine 5-phosphate decarboxylase. Hereditary oratic aciduria is also known as uridine monophosphate synthase deficiency. This rare congenital autosomal recessive disorder of pyrimidine metabolism is caused by defect in uridine monophosphate synthase. Hereditary oratic aciduria is one of the rare metabolic disorder, which has been reported in approximately 20 patients worldwide according to FDA. The symptoms of the disease include growth retardation, mental retardation, megaloblastic anemia, immunodeficiency and high level of oratic acids in urine. The inability to convert orotic acid results in body being unable to normally synthesize uridine, a necessary component of RNA which leads to failure to thrive. Hereditary orotic aciduria patients are administered with cytidine monophosphate and uridine monophosphate to reduce urinary orotic acid and anemia. Patient may also administrated with uridine, which converted into UMP and provide a source of pyrimidine for the body.

Hereditary Orotic Aciduria treatment Market: Drivers and Restraints

Hereditary orotic aciduria treatment market shows growth in forecast period due to increasing healthcare awareness and healthcare expenditure. Hereditary oratic aciduria is rare autosomal disorder so manufacture are finding new solution for treatment of disease. Increasing research and development in pharmaceutical and molecular science is also a factor which increase growth of hereditary orotic aciduria treatment market.

Request Sample Report@ https://www.persistencemarketresearch.com/samples/22873

Hereditary Orotic Aciduria treatment Market: Segmentation

On the basis of drug type the Hereditary Orotic Aciduria treatment market can be segmented as

Cytidine monophosphate
Uridine monophosphate
On the basis of indication the Hereditary Orotic Aciduria treatment market can be segmented as:

Type I
Type II
On the basis of distribution channel the Hereditary Orotic Aciduria treatment market can be segmented as:

Hospital pharmacies
Retail pharmacies
Online
Others
Hereditary Orotic Aciduria treatment Market: Overview

Hereditary orotic aciduria treatment market is growth because of increase in clinical trials to develop drugs for proper treatment of this disorder. Orotic acid from the de novo pyrimidine pathway that cannot be converted to UMP is excreted in urine, accounting for common name of disorder, orotic aciduria. Uridine triacetate is one the effective drug used for hereditary orotic aciduria treatment. Uridine triacetate majorly orally administered. Uridine triacetate is a pyrimidine analog. These drug works by replacing the uridine that cannot be normally produced in patients with hereditary orotic aciduria. Hereditary orotic aciduria is unique because was through of unique because loss of two enzymes. It is now known that these activities resides in different domains of single polypeptide coded by a single gene. Hereditary orotic aciduria patients have a macrocytic hypochromic megloblastic anemia and orotic acid crystalluria. Majority of patients have been treated with uridine with good effects in majority. Some of the patients require continued therapy.

Request TOC@ https://www.persistencemarketresearch.com/methodology/22873

Hereditary Orotic Aciduria treatment Market: Region-wise Outlook

In terms of geography, hereditary orotic aciduria treatment market has been divided into five regions including North- America, Asia- Pacific, Middle-East & Africa, Latin America, and Europe. North America dominated the global hereditary orotic aciduria treatment market as followed by Europe. North America region dominates the hereditary orotic aciduria market due their increasing research and development in pharmaceutical industry. In Asian Pacific, India and China will be the main market for the growth of the hereditary orotic aciduria treatment market.

Hereditary Orotic Aciduria treatment Market: Key Market Participants

Example of some of the market participants in global hereditary orotic aciduria treatment market identified across the value chain includes Merck & Co. Inc., Cyman Chemical and Wellstat Therapeutics Corporation are leading companies in the market which have the highest contribution to hereditary orotic aciduria treatment market.

ABOUT US:
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance. To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

CONTACT:
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sales Revenue of Hereditary Orotic Aciduria treatment Market to Soar in the Near Future Owing to Growing Consumer Adoption here

News-ID: 1445750 • Views: 232

More Releases from Persistence Market Research

Global Waterborne Coatings Market Revenue to Witness Steady Growth Through 2020
Waterborne coatings are green substrates using water as solvent to dissolve a resin, making them environment friendly and easy to apply. These coatings usually contain approximately 80% of water with minimum quantities of other solvents such as glycol ethers. As per the U.S. and European regulations of waterborne coatings to have a VOC content less than 3.5 gallons of water, these are considered eco-friendly in nature. Various types of coatings
Manufacturers to Benefit from Lucrative Growth Prospects in the Global Textile P …
Application of coloring pattern and design to decorate the finished fabric is referred as printing. At the time of printing the color is applied to the fabric so that the color or design is not affected at the time of washing. Textile printing is a process of applying color to fabric in definite pattern and design. Textile printing is sometime confused with dyeing. In dyeing whole fabric is uniformly colored
Demand for Triazole Fungicides to Rise Significantly from Key End-use Industry S …
The growth of the crop can be affected by fungal infection. Fungicides are chemical compound used to kill fungi or fungal spores. Triazole is most widely used fungicides due to their different uses and efficacy against a number of fungal diseases. Triazole is highly effective against many different fungal diseases include rusts, leaf-spotting fungi and powdery mildews. Triazole is used on field crops, fruit trees and vegetables. Repeated use
Global Purified Terephthalic Acid Market Revenue to Witness Rapid Growth in the …
Purified terephthalic acid (PTA) is a chemical which is synthesized from crude oil. It is majorly used to manufacture polyester fiber. Its end-user industries include textile and home furnishing where PTA is required to manufacture garments such as bed sheets, curtains and clothes. Request For Report Sample@https://www.persistencemarketresearch.com/samples/3434 The market for purified terephthalic is expected to witness noticeable expansion in the coming years with the growing demand for polyester, specifically in

All 5 Releases


More Releases for Hereditary

Global Hereditary Angioedema Market Forecast to 2021 - Market Reports Online
Global Hereditary Angioedema Market: Industry Analysis & Outlook (2017-2021) (http://www.marketreportsonline.com/contacts/purchase.php?name=608604) market research report available in US $ 800 only at marketrepotrsonline.com This report hereditary angioedema analyses the development of this market, with focus on the U.S. and European markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four major players Shire Plc., CSL Limited, Pharming Group
Hereditary Angioedema Market Current Overview by 2025
flow of blood or lymphatic fluid, continuous accumulation of fluids outside of the blood vessels, results in swelling of tissues in the arms, feet, intestinal tract, face, or airway. Stress or Minor trauma may also trigger an attack, Swelling in the airway can limit breathing and prompt to life-debilitating obstruction of the airway. Around 33% of individuals with this condition faces non-itchy rash called erythema marginatum at the time of
Hereditary Angioedema Market is propelled by rise in hereditary angioedema (HAE) …
Some of the prominent names operating in the global hereditary angioedema market are Pharming Group NV, Shire plc, CSL Limited, Ionis Pharmaceuticals, Inc., iBio Inc., and BioCryst Pharmaceuticals, Inc. As per a report by Transparency Market Research, the global hereditary angioedema market will likely rise at a healthy 9.1% CAGR between 2017 and 2025 to become worth US$3.81 bn by 2025 from US$ 1.73 bn in 2016. Read Report Overview: https://www.transparencymarketresearch.com/hereditary-angioedema-market.html Superior Healthcare
01-03-2018 | Health & Medicine
TMR
Hereditary Angioedema Market to Incur Rapid Extension During 2017-2025
Some of the prominent names operating in the global hereditary angioedema market are Pharming Group NV, Shire plc, CSL Limited, Ionis Pharmaceuticals, Inc., iBio Inc., and BioCryst Pharmaceuticals, Inc. As per a report by Transparency Market Research, the global hereditary angioedema market will likely rise at a healthy 9.1% CAGR between 2017 and 2025 to become worth US$3.81 bn by 2025 from US$ 1.73 bn in 2016. Request to view Sample Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=17135 Superior Healthcare
Hereditary Angioedema Market Analysis & Key Trends 2025
As per a report by Transparency Market Research, the global hereditary angioedema market will likely rise at a healthy 9.1% CAGR between 2017 and 2025 to become worth US$3.81 bn by 2025 from US$ 1.73 bn in 2016. Progress in Diagnosis Catalyzing Growth in Market Hereditary angioedema is a rare disease that is estimated to affect 1 in 30,000 to 1 in 50,000 people worldwide. Hereditary angioedema is often mistaken for common
Hereditary Angioedema Market : Global Forecast over 2025
As per a report by Transparency Market Research, the global hereditary angioedema market will likely rise at a healthy 9.1% CAGR between 2017 and 2025 to become worth US$3.81 bn by 2025 from US$ 1.73 bn in 2016. Superior Healthcare Facilities Makes North America Market Leader Depending upon the class of drugs, the global hereditary angioedema market can be segmented into C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, and Kallikrein Inhibitor,